The Framework outlined our leadership priorities and articulated the opportunities we saw across our businesses.
Under the Framework, we targeted generating $26 billion to $30 billion of cash through 2019, returning more than $12.5 billion to shareholders and investing $10 billion to extend our leadership positions and deliver growth.
As of June 30, 2019, Corning met its goal of returning more than $12.5 billion to shareholders and is on track to invest $11 billion for growth and extended leadership.
From 2020 to 2023, the company plans to invest $10 billion to $12 billion for growth and to return $8 billion to $10 billion to shareholders.
Life Sciences net sales increased by $25 million, as volume grew faster than the underlying market.
Life Sciences net sales increased by $51 million, as volume grew faster than the underlying market.
Lower segment net income of $33 million, $41 million and $24 million for the Display Technologies, Optical Communications and Specialty Materials segments, respectively.
The decreases in net income outlined above were slightly offset by higher net income for the Environmental Technologies and Life Sciences segments of $19 million and $11 million, respectively.
In the Optical Communications segment, we expect sales to decrease three to five percent year-over-year.
Life Sciences net sales increased by $25 million, as volume grew faster than the underlying market.
Movements in foreign exchange rates did not materially impact Corning’s consolidated net sales in the three months ended September 30, 2019, when compared to the prior year.
Life Sciences net sales increased by $51 million, as volume grew faster than the underlying market.
Movements in foreign exchange rates did not materially impact Corning’s consolidated net sales in the nine months ended September 30, 2019, when compared to the prior year.
When compared to the first nine months of 2018, selling, general and administrative expenses decreased by $168 million, or 12%, in the nine months ended September 30, 2019.
Selling, general and administrative expenses declined as a percentage of sales by 2% for the three and nine months ended September 30, 2019.
For the three and nine months ended September 30, 2019, research, development and engineering expenses increased by $11 million, or 5%, and $25 million, or 3%, respectively, when compared to the same periods last year, driven by higher costs associated with new product launches and our emerging businesses.
In the third quarter ending September 30, 2019, equity in earnings of affiliated companies declined by $9 million primarily driven by lower sales volumes for some of our affiliates.Risks disclosed in our 2018 Form 10-K are not the only risks facing our Company.